Advertisement

Reactions Weekly

, Volume 1748, Issue 1, pp 170–170 | Cite as

Dasatinib/nilotinib

Cardiovascular events: 9 case reports
Case report
  • 16 Downloads

Reference

  1. Assuncao PM, et al. Cardiovascular Risk and Cardiovascular Events in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors. Clinical Lymphoma, Myeloma & Leukemia 19: 162-166, No. 3, Mar 2019. Available from: URL: http://doi.org/10.1016/j.clml.2018.12.004 - Brazil

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations